Skip to content

Pediatric Vasculitis Initiative

Takayasu Arteritis | Eosinophilic Granulomatosis With Polyangiitis | Microscopic Polyangiitis | Polyarteritis...

Childhood chronic vasculitis describes a group of rare life-threatening diseases that have in common inflammation of blood vessels in vital organs such as kidneys, lungs and brain. Most knowledge about them comes from adult patients. Severe disease requires aggressive life-saving treatments with steroids and some cancer drugs which can themselves cause damage, and increase risks of cancer and severe infections. Conversely, milder disease can be treated with less toxic drugs. Different classification and "scoring tools" are used to define the types and severity of vasculitis and to measure damage caused by disease or drugs. These in turn help direct how aggressively to treat a patient and to measure outcome. None of these tools however have been assessed in children and the best balance of disease and treatment risks against outcome for children is not known. Although causes of these diseases in children and adults are probably the same, the effects of the disease and the response (good and bad) to drugs will differ in growing children. Because specialists may see only one new child with vasculitis each year, obtaining enough information to learn about childhood vasculitis requires cooperation. We will use an international web-based registry to which doctors from 50 or more centers can contribute patient data. We will determine the features which help better classify and diagnose children compared to adults. Through the web we will collect and analyze information on patients similarly classified and "scored" so that most successful treatments can be identified. Children with vasculitis are less likely to have diseases associated with aging, alcohol and smoking etc., and therefore may be a better group in whom to study the underlying biology of vasculitis. We will use this opportunity and collect spit, blood and tissue from registry patients for laboratory study with an aim to find biomarkers to better classify, define and direct optimal treatment and outcomes.

null

Conditions de participation

  • Sexe:

    ALL
  • Âges admissibles:

    0 to 20

Critères de participation

Inclusion criteria for vasculitis subjects:

* Diagnosed with ANCA-associated vasculitis (AAV: such as Granulomatosis with Polyangiitis (GPA), Eosinophilic Granulomatosis with Polyangiitis (EGPA) and Microscopic Polyangiitis (MPA)), Primary Angiitis of the Central Nervous System (PACNS), Unclassified vasculitis, Takayasu's Arteritis (TA) or Polyarteritis Nodosa (PAN) before age 18

Inclusion criteria for healthy controls:

* Healthy adult or child

Exclusion Criteria for vasculitis subjects:

* Diagnosed with other vasculitis subtypes not listed above
* More than 20 years of age

Exclusion criteria for healthy controls:

* Donated greater than 20 ml of blood in the previous three weeks
* Has an immune disorder or blood borne infectious diseases (such as HIV or Hepatitis)
* Has vasculitis, multiple sclerosis, diabetes, an autoimmune disease, a thyroid condition, or other chronic conditions involving the heart, lungs, gut or kidney
* Has a previous history of anaemia or abnormal blood clotting
* Has a current or previous drug abuse problem

Lieu de l'étude

University of Calgary / Alberta Children's Hospital
University of Calgary / Alberta Children's Hospital
Calgary, Alberta
Canada

Contactez l'équipe d'étude

London Health Sciences Centre
London Health Sciences Centre
London, Ontario
Canada

Contactez l'équipe d'étude

IIWK Health Centre
IIWK Health Centre
Halifax, Nova Scotia
Canada

Contactez l'équipe d'étude

Royal University Hospital
Royal University Hospital
Saskatoon, Saskatchewan
Canada

Contactez l'équipe d'étude

BC Children's Hospital
BC Children's Hospital
Vancouver, British Columbia
Canada

Contactez l'équipe d'étude

Children's Hospital of Eastern Ontario
Children's Hospital of Eastern Ontario
Ottawa, Ontario
Canada

Contactez l'équipe d'étude

Janeway Childrens Health and Rehabilitation Centre
Janeway Childrens Health and Rehabilitation Centre
St. John's, Newfoundland and Labrador
Canada

Contactez l'équipe d'étude

Hospital for Sick Children
Hospital for Sick Children
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Étude parrainée par
University of British Columbia
Participants recherchés
Plus d'informations
ID de l'étude: NCT02006134